Tikun Olam-Cannbit Pharmaceuticals Ltd (TKUNF)

TKUNF Revenue

In the year 2024, Tikun Olam-Cannbit Pharmaceuticals had annual revenue of 34.95M ILS, down -20.97%. Tikun Olam-Cannbit Pharmaceuticals had revenue of 14.10M in the half year ending December 31, 2024, a decrease of -49.90%.

• Revenue: 34.95M ILS
• Revenue Growth: -20.97%
• P/S Ratio: 0.65
• Revenue / Employee: 1.84M ILS
• Employees: 19
• Market Cap: 6.25M USD

Revenue Chart

* This company reports financials in ILS.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	34.95M	-9.28M	-20.97%
Dec 31, 2023	44.23M	-5.07M	-10.28%
Dec 31, 2022	49.30M	12.27M	33.13%
Dec 31, 2021	37.03M	15.37M	70.97%
Dec 31, 2020	21.66M	-	-